rs6599250

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006514.4(SCN10A):​c.1868-9A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.621 in 1,609,664 control chromosomes in the GnomAD database, including 316,134 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.70 ( 38358 hom., cov: 32)
Exomes 𝑓: 0.61 ( 277776 hom. )

Consequence

SCN10A
NM_006514.4 intron

Scores

2
Splicing: ADA: 0.00006857
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.669

Publications

22 publications found
Variant links:
Genes affected
SCN10A (HGNC:10582): (sodium voltage-gated channel alpha subunit 10) The protein encoded by this gene is a tetrodotoxin-resistant voltage-gated sodium channel alpha subunit. The properties of the channel formed by the encoded transmembrane protein can be altered by interaction with different beta subunits. This protein may be involved in the onset of pain associated with peripheral neuropathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]
SCN10A Gene-Disease associations (from GenCC):
  • sodium channelopathy-related small fiber neuropathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • episodic pain syndrome, familial, 2
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics
  • Brugada syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Genomics England PanelApp
  • Brugada syndrome 1
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 3-38742538-T-C is Benign according to our data. Variant chr3-38742538-T-C is described in ClinVar as Benign. ClinVar VariationId is 259993.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.899 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN10ANM_006514.4 linkc.1868-9A>G intron_variant Intron 13 of 27 ENST00000449082.3 NP_006505.4 Q9Y5Y9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN10AENST00000449082.3 linkc.1868-9A>G intron_variant Intron 13 of 27 1 NM_006514.4 ENSP00000390600.2 Q9Y5Y9
SCN10AENST00000643924.1 linkc.1868-9A>G intron_variant Intron 12 of 26 ENSP00000495595.1 A0A2R8Y6J6
SCN10AENST00000655275.1 linkc.1895-9A>G intron_variant Intron 13 of 27 ENSP00000499510.1 A0A590UJM0

Frequencies

GnomAD3 genomes
AF:
0.696
AC:
105735
AN:
151962
Hom.:
38285
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.906
Gnomad AMI
AF:
0.552
Gnomad AMR
AF:
0.669
Gnomad ASJ
AF:
0.606
Gnomad EAS
AF:
0.859
Gnomad SAS
AF:
0.660
Gnomad FIN
AF:
0.534
Gnomad MID
AF:
0.601
Gnomad NFE
AF:
0.597
Gnomad OTH
AF:
0.647
GnomAD2 exomes
AF:
0.649
AC:
161550
AN:
248812
AF XY:
0.641
show subpopulations
Gnomad AFR exome
AF:
0.911
Gnomad AMR exome
AF:
0.686
Gnomad ASJ exome
AF:
0.602
Gnomad EAS exome
AF:
0.860
Gnomad FIN exome
AF:
0.540
Gnomad NFE exome
AF:
0.596
Gnomad OTH exome
AF:
0.615
GnomAD4 exome
AF:
0.614
AC:
894283
AN:
1457584
Hom.:
277776
Cov.:
32
AF XY:
0.613
AC XY:
444436
AN XY:
725452
show subpopulations
African (AFR)
AF:
0.916
AC:
30636
AN:
33436
American (AMR)
AF:
0.684
AC:
30579
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.601
AC:
15685
AN:
26112
East Asian (EAS)
AF:
0.858
AC:
34024
AN:
39674
South Asian (SAS)
AF:
0.637
AC:
54914
AN:
86186
European-Finnish (FIN)
AF:
0.542
AC:
28835
AN:
53200
Middle Eastern (MID)
AF:
0.535
AC:
3078
AN:
5748
European-Non Finnish (NFE)
AF:
0.594
AC:
658567
AN:
1108246
Other (OTH)
AF:
0.630
AC:
37965
AN:
60266
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
18794
37587
56381
75174
93968
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18134
36268
54402
72536
90670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.696
AC:
105874
AN:
152080
Hom.:
38358
Cov.:
32
AF XY:
0.694
AC XY:
51596
AN XY:
74332
show subpopulations
African (AFR)
AF:
0.907
AC:
37640
AN:
41518
American (AMR)
AF:
0.670
AC:
10243
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.606
AC:
2098
AN:
3462
East Asian (EAS)
AF:
0.860
AC:
4444
AN:
5168
South Asian (SAS)
AF:
0.661
AC:
3176
AN:
4808
European-Finnish (FIN)
AF:
0.534
AC:
5641
AN:
10558
Middle Eastern (MID)
AF:
0.602
AC:
177
AN:
294
European-Non Finnish (NFE)
AF:
0.597
AC:
40581
AN:
67952
Other (OTH)
AF:
0.649
AC:
1372
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1539
3079
4618
6158
7697
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
810
1620
2430
3240
4050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.644
Hom.:
53933
Bravo
AF:
0.715
Asia WGS
AF:
0.769
AC:
2675
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 04, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 06, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Brugada syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Episodic pain syndrome, familial, 2 Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
8.9
DANN
Benign
0.71
PhyloP100
-0.67
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000069
dbscSNV1_RF
Benign
0.010
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6599250; hg19: chr3-38784029; API